Download PDF
Am J Perinatol 2017; 34(06): 585-592
DOI: 10.1055/s-0036-1594017
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Preeclampsia and the Risk of Bronchopulmonary Dysplasia in Preterm Infants Less Than 32 Weeks' Gestation

Nancy Soliman
1   Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Alberta, Canada
,
Kathleen Chaput
2   Department of Pediatrics, Cumming School of Medicine, University of Calgary, Alberta, Canada
,
Belal Alshaikh
3   Department of Pediatrics, Section of Neonatology, Cumming School of Medicine, University of Calgary, Alberta, Canada
,
Kamran Yusuf
3   Department of Pediatrics, Section of Neonatology, Cumming School of Medicine, University of Calgary, Alberta, Canada
› Author Affiliations
Further Information

Publication History

08 August 2016

04 October 2016

Publication Date:
05 December 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Objective Angiogenesis is essential for normal lung development. The objective of our study was to test the hypothesis that preeclampsia, an antiangiogenic state, is a risk factor for bronchopulmonary dysplasia (BPD).

Design Prospective cohort study of infants less than 32 weeks' gestation born to mothers with preeclampsia between January 2007 and June 2010 at a single tertiary care center. Their BPD outcome was compared with infants born to the next two normotensive mothers with a ± 1 week gestational age difference. BPD was defined as oxygen dependency at 36 weeks' postmenstrual age. Multivariable binary regression was used to estimate the risk ratio (RR) of BPD with preeclampsia exposure and adjust for confounders.

Results Of 102 infants in the preeclampsia group, 23 (23%) developed BPD and of the 217 infants in the normotensive group, 56 (26%) developed BPD. On multivariable binary regression modeling, preeclampsia was not a risk factor for development of BPD (RR: 0.5, 95% confidence interval [CI]: 0.20–1.20). Surfactant use, Score for Neonatal Acute Physiology Perinatal Extension-II score, sepsis, blood transfusion, and intrauterine growth restriction (IUGR) were significant risk factors for BPD.

Conclusion In our cohort, preeclampsia was not a significant risk factor for BPD. IUGR infants of preeclamptic and normotensive mothers were at higher risk for BPD.

Keywords

preeclampsia - bronchopulmonary dysplasia - lung development - IUGR - angiogenic factors - antiangiogenic factors - preterm neonate - risk factor
 

  • References

  • 1 Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357 (19) 1946-1955
    CrossrefPubMedGoogle Scholar
  • 2 Thebaud B. Chronic lung disease in the neonate: past, present and future. Neoreviews 2013; 14 (5) e252-e258
    CrossrefPubMedGoogle Scholar
  • 3 Jobe AH. The new BPD. Neoreviews 2006; 7 (10) e531-e545
    CrossrefPubMedGoogle Scholar
  • 4 Thébaud B. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology 2007; 91 (4) 291-297
    CrossrefPubMedGoogle Scholar
  • 5 Hadchouel A, Franco-Montoya ML, Delacourt C. Altered lung development in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014; 100 (3) 158-167
    CrossrefPubMedGoogle Scholar
  • 6 Meller S, Bhandari V. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Exp Lung Res 2012; 38 (4) 192-203
    CrossrefPubMedGoogle Scholar
  • 7 Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Pediatrics 2009; 123 (6) 1541-1547
    CrossrefPubMedGoogle Scholar
  • 8 Janér J, Andersson S, Haglund C, Lassus P. Pulmonary endostatin perinatally and in lung injury of the newborn infant. Pediatrics 2007; 119 (1) e241-e246
    CrossrefPubMedGoogle Scholar
  • 9 Mohamed WA, Niyazy WH, Mahfouz AA. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Trop Pediatr 2011; 57 (5) 385-388
    CrossrefPubMedGoogle Scholar
  • 10 Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10 (8) 466-480
    CrossrefPubMedGoogle Scholar
  • 11 Pratt A, Da Silva Costa F, Borg AJ, Kalionis B, Keogh R, Murthi P. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis 2015; 18 (2) 115-123
    CrossrefPubMedGoogle Scholar
  • 12 Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005; 1 (2) 98-114 , quiz 120
    CrossrefPubMedGoogle Scholar
  • 13 Reilly SD, Faye-Petersen OM. Chorioaminionitis and funisitis: their implications for the neonate. Neoreviews 2008; 9 (9) e411-e417
    CrossrefPubMedGoogle Scholar
  • 14 Kuperman AA, Kenet G, Papadakis E, Brenner B. Intraventricular hemorrhage in preterm infants: coagulation perspectives. Semin Thromb Hemost 2011; 37 (7) 730-736
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Dominguez KM, Moss RL. Necrotizing enterocolitis. Clin Perinatol 2012; 39 (2) 387-401
    CrossrefPubMedGoogle Scholar
  • 16 Kramer MS, Platt RW, Wen SW , et al; Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108 (2) E35 . Doi: 10.1542/peds.108.2.e35
    CrossrefPubMedGoogle Scholar
  • 17 Bose C, Van Marter LJ, Laughon M , et al; Extremely Low Gestational Age Newborn Study Investigators. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 2009; 124 (3) e450-e458
    CrossrefPubMedGoogle Scholar
  • 18 Klinger G, Sokolover N, Boyko V, Sirota L, Lerner-Geva L, Reichman B ; Israel Neonatal Network. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants. Am J Obstet Gynecol 2013; 208 (2) 115.e1-115.e9
    CrossrefPubMedGoogle Scholar
  • 19 Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014; 100 (3) 145-157
    CrossrefPubMedGoogle Scholar
  • 20 Christenfeld NJ, Sloan RP, Carroll D, Greenland S. Risk factors, confounding, and the illusion of statistical control. Psychosom Med 2004; 66 (6) 868-875
    CrossrefPubMedGoogle Scholar
  • 21 Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009; 20 (4) 488-495
    CrossrefPubMedGoogle Scholar
  • 22 Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996; 49 (8) 907-916
    CrossrefPubMedGoogle Scholar
  • 23 Torchin H, Ancel PY, Goffinet F , et al. Placental complications and bronchopulmonary dysplasia: EPIPAGE-2 cohort study. Pediatrics 2016; 137 (3) e20152163 . Doi: 10.1542/peds.2015-2163
    CrossrefPubMedGoogle Scholar
  • 24 Briana DD, Malamitsi-Puchner A. Small for gestational age birth weight: impact on lung structure and function. Paediatr Respir Rev 2013; 14 (4) 256-262
    PubMedGoogle Scholar
  • 25 Mestan KK, Steinhorn RH. Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2011; 301 (6) L858-L859
    CrossrefPubMedGoogle Scholar
  • 26 Rozance PJ, Seedorf GJ, Brown A , et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011; 301 (6) L860-L871
    CrossrefPubMedGoogle Scholar
  • 27 Lipsett J, Tamblyn M, Madigan K , et al. Restricted fetal growth and lung development: a morphometric analysis of pulmonary structure. Pediatr Pulmonol 2006; 41 (12) 1138-1145
    CrossrefPubMedGoogle Scholar
  • 28 Wignarajah D, Cock ML, Pinkerton KE, Harding R. Influence of intrauterine growth restriction on airway development in fetal and postnatal sheep. Pediatr Res 2002; 51 (6) 681-688
    CrossrefPubMedGoogle Scholar
  • 29 Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003; 110 (Suppl. 01) S99-S107
    CrossrefPubMedGoogle Scholar
  • 30 Sureshbabu A, Syed MA, Boddupalli CS , et al. Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung. Respir Res 2015; 16 (1) 4 . Doi: 10.1186/s12931-014-0162-6
    CrossrefPubMedGoogle Scholar
  • 31 Ambalavanan N, Nicola T, Hagood J , et al. Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 2008; 295 (1) L86-L95
    CrossrefPubMedGoogle Scholar
  • 32 Been JV, Debeer A, van Iwaarden JF , et al. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Res 2010; 67 (1) 83-89
    CrossrefPubMedGoogle Scholar
  • 33 Toti P, Buonocore G, Tanganelli P , et al. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol 1997; 24 (1) 22-28
    CrossrefPubMedGoogle Scholar
  • 34 Briana DD, Liosi S, Gourgiotis D , et al. Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term. Cytokine 2012; 60 (1) 157-161
    CrossrefPubMedGoogle Scholar
  • 35 Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP, Hassiakos D. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev 2006; 82 (4) 235-239
    CrossrefPubMedGoogle Scholar
  • 36 Hentges CR, Silveira RC, Procianoy RS. Angiogenic and antiangiogenic factors in preterm neonates born to mothers with and without preeclampsia. Am J Perinatol 2015; 32 (12) 1185-1190
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Ozkan H, Cetinkaya M, Koksal N. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia. J Matern Fetal Neonatal Med 2012; 25 (12) 2681-2685
    CrossrefPubMedGoogle Scholar
  • 38 Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?. J Perinatol 2009; 29 (10) 680-684
    CrossrefPubMedGoogle Scholar
  • 39 Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease?. BJOG 2004; 111 (4) 298-302
    CrossrefPubMedGoogle Scholar
  • 40 Thébaud B, Lacaze-Masmonteil T. If your placenta doesn't have it, chances are your lungs don't have it either: the “vascular hypothesis” of bronchopulmonary dysplasia starts in utero. J Pediatr 2010; 156 (4) 521-523
    CrossrefPubMedGoogle Scholar
  • 41 O'Shea JE, Davis PG, Doyle LW ; Victorian Infant Collaborative Study Group. Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants. Pediatr Res 2012; 71 (2) 210-214
    CrossrefPubMedGoogle Scholar
  • 42 Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol 2006; 26 (7) 428-435
    CrossrefPubMedGoogle Scholar
  • 43 Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156 (4) 532-536
    CrossrefPubMedGoogle Scholar
  • 44 Kalay S, Cakcak B, Oztekin O , et al. The role of VEGF and its soluble receptor VEGFR-1 in preterm newborns of preeclamptic mothers with RDS. J Matern Fetal Neonatal Med 2013; 26 (10) 978-983
    CrossrefPubMedGoogle Scholar
  • 45 Schlembach D, Wallner W, Sengenberger R , et al. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2007; 29 (4) 407-413
    CrossrefPubMedGoogle Scholar
  • 46 Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 122 (1) 33-39
    CrossrefPubMedGoogle Scholar
  • 47 Staff AC, Braekke K, Johnsen GM, Karumanchi SA, Harsem NK. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol 2007; 197 (2) 176.e1-176.e6
    CrossrefPubMedGoogle Scholar
  • 48 Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 2005; 193 (3 Pt 2): 984-989
    CrossrefPubMedGoogle Scholar
  • 49 Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012; 302 (1) L36-L46
    CrossrefPubMedGoogle Scholar
  • 50 Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195 (1) 40-49
    PubMedGoogle Scholar
  • 51 Vatten LJ, Åsvold BO, Eskild A. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Acta Obstet Gynecol Scand 2012; 91 (12) 1388-1394
    CrossrefPubMedGoogle Scholar
  • 52 Wender-Ozegowska E, Zawiejska A, Iciek R, Brązert J. Concentrations of eNOS, VEGF, ACE and PlGF in maternal blood as predictors of impaired fetal growth in pregnancy complicated by gestational hypertension/preeclampsia. Hypertens Pregnancy 2015; 34 (1) 17-23
    CrossrefPubMedGoogle Scholar
  • 53 Wathén KA, Ylikorkala O, Andersson S, Alfthan H, Stenman UH, Vuorela P. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Acta Obstet Gynecol Scand 2009; 88 (5) 593-598
    CrossrefPubMedGoogle Scholar
  • 54 Yen TA, Yang HI, Hsieh WS , et al; Taiwan Premature Infant Developmental Collaborative Study Group. Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study. PLoS One 2013; 8 (9) e75168 . Doi: 10.1371/journal.pone.0075168
    CrossrefPubMedGoogle Scholar
  • 55 Tsao PN, Wei SC, Su YN , et al. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. Pediatrics 2004; 113 (5) 1348-1351
    CrossrefPubMedGoogle Scholar
  • 56 Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002; 52 (5) 713-719
    CrossrefPubMedGoogle Scholar
  • 57 Kim YM, Chaemsaithong P, Romero R , et al. The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion. J Matern Fetal Neonatal Med 2015; 28 (17) 2001-2009
    CrossrefPubMedGoogle Scholar
  • 58 Shah DM, Shenai JP, Vaughn WK. Neonatal outcome of premature infants of mothers with preeclampsia. J Perinatol 1995; 15 (4) 264-267
    PubMedGoogle Scholar
  • 59 Withagen MIJ, Visser W, Wallenburg HCS. Neonatal outcome of temporizing treatment in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 94 (2) 211-215
    CrossrefPubMedGoogle Scholar
  • 60 Hiett AK, Brown HL, Britton KA. Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia. J Matern Fetal Med 2001; 10 (5) 301-304
    PubMedGoogle Scholar
  • 61 Zeitlin J, El Ayoubi M, Jarreau PH , et al; MOSAIC Research Group. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 2010; 157 (5) 733-9.e1
    Google Scholar
  • 62 Been JV, Zimmermann LJ. Histological chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94 (3) F218-F225
    CrossrefPubMedGoogle Scholar
  • 63 Lapcharoensap W, Gage SC, Kan P , et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr 2015; 169 (2) e143676 . Doi: 10.1001/jamapediatrics.2014.3676
    CrossrefPubMedGoogle Scholar